Hangzhou Coco Healthcare Products Co.,Ltd.

Sümbol: 301009.SZ

SHZ

9.21

CNY

Turuhind täna

89.9693
P/E suhe
0.0000
PEG suhe
2.50B
MRK Cap
0.00%
DIV tootlus

Hangzhou Coco Healthcare Products Co.,Ltd. (301009-SZ) Finantsaruanded

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Hangzhou Coco Healthcare Products Co.,Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln USD Growth	2022	2020	2018
balance-sheet.row.cash-and-short-term-investments	863.1	689.5	884	439.2	200.4	231	244.4
balance-sheet.row.short-term-investments	-20.4	-21.2	-23.5	100	20	0	0.3
balance-sheet.row.net-receivables	213	274.5	188.2	247.1	200.6	199.2	183.5
balance-sheet.row.inventory	114.8	182.4	153.9	127.8	134.3	115.3	124.1
balance-sheet.row.other-current-assets	13.9	12.2	27.6	35.4	34.7	10.1	4.4
balance-sheet.row.total-current-assets	1204.7	1158.5	1253.8	849.5	570	555.5	556.4
balance-sheet.row.property-plant-equipment-net	663.4	670.4	694.8	536.1	416.2	351	330.4
balance-sheet.row.goodwill	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	82.5	84.9	87	50.8	52.1	53.2	39.2
balance-sheet.row.goodwill-and-intangible-assets	82.5	84.9	87	50.8	52.1	53.2	39.2
balance-sheet.row.long-term-investments	30.1	21.5	23.7	-99.8	8.1	9.4	9.3
balance-sheet.row.tax-assets	10.1	8.2	2.1	5.9	2.3	2.3	3.9
balance-sheet.row.other-non-current-assets	1.2	5.2	24.2	151.5	23.3	24.7	27.2
balance-sheet.row.total-non-current-assets	787.3	790.1	831.8	644.5	502	440.7	400.7
balance-sheet.row.other-assets	0	0	0	0	0	0	0
balance-sheet.row.total-assets	1992	1948.6	2085.6	1494	1071.9	996.3	957.1
balance-sheet.row.account-payables	439	429.9	528.5	653.3	515.2	407	397.1
balance-sheet.row.short-term-debt	6.2	1.4	1.5	99.2	40.9	11	50
balance-sheet.row.tax-payables	5.5	6.5	1.4	23.8	20.5	7.1	3.2
balance-sheet.row.long-term-debt-total	11.9	3.3	5.1	0	0	0	0
Deferred Revenue Non Current	45.2	39.1	6.8	6.7	6	4.6	2
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	0.6	0.8	0.6	0.2	4.1	5.3	35.5
balance-sheet.row.total-non-current-liabilities	57.1	42.3	11.9	6.7	6	4.6	2
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	11.9	3.3	5.1	0	0	0	0
balance-sheet.row.total-liab	542.4	516.9	578.6	812.4	613.9	460.6	484.6
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0
balance-sheet.row.common-stock	271.9	271.9	271.9	203.9	203.9	199.9	199.9
balance-sheet.row.retained-earnings	300.4	284.3	348.8	314.9	117.7	237	183.2
balance-sheet.row.accumulated-other-comprehensive-income-loss	0	73.2	70.8	94.7	77.4	0	0
balance-sheet.row.other-total-stockholders-equity	800.4	723.2	723.2	0	0	45.9	47.9
balance-sheet.row.total-stockholders-equity	1372.7	1352.6	1414.7	613.4	399	482.8	431
balance-sheet.row.total-liabilities-and-stockholders-equity	1992	1948.6	2085.6	1494	1071.9	996.3	957.1
balance-sheet.row.minority-interest	76.9	79.2	92.3	68.1	59	52.8	41.6
balance-sheet.row.total-equity	1449.6	1431.8	1507	681.5	458	535.6	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-
Total Investments	9.7	0.3	0.3	0.3	8.1	9.4	0.3
balance-sheet.row.total-debt	18.1	4.6	6.6	99.2	40.9	11	50
balance-sheet.row.net-debt	-845	-684.8	-877.4	-240.1	-159.5	-220	-194.1

Rahavoogude aruanne

Hangzhou Coco Healthcare Products Co.,Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	2021	2019	2017
cash-flows.row.net-income	-56.2	39.4	223.1	93.5	61.7	47.9
cash-flows.row.depreciation-and-amortization	61.3	49.4	39.2	32.2	29.6	25.1
cash-flows.row.deferred-income-tax	-6.1	3.8	-3.6	0	0	0
cash-flows.row.stock-based-compensation	6.1	-3.8	3.6	0	0	0
cash-flows.row.change-in-working-capital	-110.7	-53.8	67.3	74.8	16.7	26.2
cash-flows.row.account-receivables	-31	114.1	-101.2	-22.6	0	0
cash-flows.row.inventory	-40.2	-34	4.5	-20.6	8.4	-43.3
cash-flows.row.account-payables	-33.5	-137.7	167.6	118	0	0
cash-flows.row.other-working-capital	-6.1	3.8	-3.6	0	8.3	69.5
cash-flows.row.other-non-cash-items	68.5	15.4	66.2	22.9	6.3	10.6
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-116.4	-240.4	-220.7	-125.9	-89.8	-77.4
cash-flows.row.acquisitions-net	0.6	25	0.1	0.3	0	11
cash-flows.row.purchases-of-investments	-65	-95	-150.3	-88	-17	-187.3
cash-flows.row.sales-maturities-of-investments	65.2	220.1	51.1	68.6	17	189
cash-flows.row.other-investing-activites	3.4	-24.5	8.3	9.3	-0.4	24
cash-flows.row.net-cash-used-for-investing-activites	-112.1	-114.9	-311.5	-135.7	-90.2	-51.8
cash-flows.row.debt-repayment	0	-149.1	-80.6	-11	-25	0
cash-flows.row.common-stock-issued	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0
cash-flows.row.dividends-paid	-19	-0.9	-23.6	-180.5	-1.5	-46.6
cash-flows.row.other-financing-activites	-30.8	833.8	132.7	53.8	-14	10
cash-flows.row.net-cash-used-provided-by-financing-activities	-49.9	683.8	28.5	-137.7	-40.5	-36.6
cash-flows.row.effect-of-forex-changes-on-cash	4.2	-2.6	-11.6	1.6	0.8	-4.6
cash-flows.row.net-change-in-cash	-195	616.8	101.2	-48.4	-15.7	16.7
cash-flows.row.cash-at-end-of-period	639.5	834.4	217.6	116.4	164.8	180.5
cash-flows.row.cash-at-beginning-of-period	834.4	217.6	116.4	164.8	180.5	163.8
cash-flows.row.operating-cash-flow	-37.2	50.5	395.9	223.3	114.3	109.7
cash-flows.row.capital-expenditure	-116.4	-240.4	-220.7	-125.9	-89.8	-77.4
cash-flows.row.free-cash-flow	-153.6	-189.9	175.1	97.5	24.5	32.3

Kasumiaruande rida

Hangzhou Coco Healthcare Products Co.,Ltd. tulud muutusid võrreldes eelmise perioodiga NaN%. 301009.SZ brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln USD Growth	2022	2020	2018
income-statement-row.row.total-revenue	1081.5	1186.3	1186.4	1635.1	1173.7	906.2	786.9
income-statement-row.row.cost-of-revenue	890.6	1030.9	965.3	1180.1	856.6	675.4	561.9
income-statement-row.row.gross-profit	190.9	155.4	221.1	455	317.2	230.8	225
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-0.8	-0.9	-1.8	21.3	-20	-12.2	36.7
income-statement-row.row.operating-expenses	175.2	171.3	176.8	138.8	204.5	163.4	166
income-statement-row.row.cost-and-expenses	1065.7	1202.2	1142.1	1318.9	1061.1	838.8	727.9
income-statement-row.row.interest-income	24.2	23.3	12.6	4.7	13.7	12.4	3.3
income-statement-row.row.interest-expense	0.7	0.3	1	4.3	5.4	4.9	7
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-0.8	-0.9	-1.8	-1.1	0.5	3.7	3
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-0.8	-0.9	-1.8	21.3	-20	-12.2	36.7
income-statement-row.row.total-operating-expenses	-0.8	-0.9	-1.8	-1.1	0.5	3.7	3
income-statement-row.row.interest-expense	0.7	0.3	1	4.3	5.4	4.9	7
income-statement-row.row.depreciation-and-amortization	56.8	61.3	49.4	39.2	32.2	29.6	25.1
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-
income-statement-row.row.operating-income	20.2	-55.5	45.3	255.4	108	66.2	50.1
income-statement-row.row.income-before-tax	19.5	-56.4	43.5	254.3	108.4	69.9	53.1
income-statement-row.row.income-tax-expense	1.7	-0.1	4.1	31.2	14.9	8.2	5.2
income-statement-row.row.net-income	20.2	-43.1	39.7	214	87.5	59.7	41.9